Stockscreener 앱 받기
28.88
2.93%
-0.8435
전일 마감가:
$29.72
열려 있는:
$29.64
하루 거래량:
181.60K
Relative Volume:
0.23
시가총액:
$823.01M
수익:
-
순이익/손실:
$-69.47M
주가수익비율:
-5.159
EPS:
-5.5973
순현금흐름:
$-73.92M
1주 성능:
-7.80%
1개월 성능:
-40.81%
6개월 성능:
-2.27%
1년 성능:
+3.29%
1일 변동 폭
$28.58
$29.64
1주일 범위
$28.58
$32.00
52주 변동 폭
$16.54
$50.40
Lenz Therapeutics Inc Stock (LENZ) Company Profile
명칭
Lenz Therapeutics Inc
전화
858-925-7000
주소
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
LENZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LENZ
Lenz Therapeutics Inc
|
28.86 | 899.65M | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.50 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.12 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
828.79 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.35 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-14 | 재개 | Piper Sandler | Overweight |
| 2025-03-18 | 개시 | TD Cowen | Buy |
| 2024-09-27 | 개시 | Raymond James | Outperform |
| 2024-08-12 | 개시 | H.C. Wainwright | Buy |
| 2024-04-15 | 개시 | Leerink Partners | Outperform |
| 2024-04-15 | 개시 | William Blair | Outperform |
| 2024-04-10 | 개시 | Citigroup | Buy |
| 2024-03-27 | 개시 | Piper Sandler | Overweight |
| 2023-02-23 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-02-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-02-23 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2023-01-25 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-01-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-01-06 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-06 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-04-14 | 개시 | BTIG Research | Buy |
| 2022-03-22 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-18 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-07-20 | 개시 | Morgan Stanley | Overweight |
| 2021-07-20 | 개시 | SVB Leerink | Outperform |
모두보기
Lenz Therapeutics Inc 주식(LENZ)의 최신 뉴스
Analyzing drawdowns of LENZ Therapeutics Inc. with statistical toolsPortfolio Return Report & Smart Allocation Stock Tips - newser.com
Combining price and volume data for LENZ Therapeutics Inc.Day Trade & AI Driven Stock Price Forecasts - newser.com
What does recent volatility data suggest for LENZ Therapeutics Inc.Buy Signal & Community Verified Trade Alerts - newser.com
Is LENZ Therapeutics Inc. trending in predictive chart modelsBull Run & Real-Time Chart Breakout Alerts - newser.com
Will LENZ Therapeutics Inc. continue its uptrendJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Ranking LENZ Therapeutics Inc. among high performing stocks via toolsInsider Buying & Technical Confirmation Trade Alerts - newser.com
Signal strength of LENZ Therapeutics Inc. stock in tech scannersTrade Ideas & Fast Moving Market Watchlists - newser.com
Why LENZ Therapeutics Inc. stock is trending among retail tradersGlobal Markets & Daily Chart Pattern Signal Reports - newser.com
Why LENZ Therapeutics Inc. stock remains on watchlistsJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com
Is LENZ Therapeutics Inc. stock ready for a breakoutJuly 2025 Drop Watch & Daily Profit Focused Stock Screening - newser.com
Real time scanner hits for LENZ Therapeutics Inc. explainedQuarterly Risk Review & Daily Oversold Bounce Ideas - newser.com
Is LENZ Therapeutics Inc. stock a buy in volatile marketsWeekly Trade Report & Low Risk High Reward Trade Ideas - newser.com
Will LENZ Therapeutics Inc. stock see PE expansionWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
How LENZ Therapeutics Inc. stock trades before earningsPortfolio Gains Report & High Win Rate Trade Alerts - newser.com
How interest rate cuts could boost LENZ Therapeutics Inc. stockShort Setup & Smart Swing Trading Alerts - newser.com
How LENZ Therapeutics Inc. stock reacts to Fed rate cutsJuly 2025 Institutional & Weekly Stock Performance Updates - newser.com
Why LENZ Therapeutics Inc. stock remains undervaluedQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Has LENZ Therapeutics Inc. formed a bullish divergence2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - newser.com
LENZ Therapeutics, Inc. (LENZ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - sharewise.com
Chart overlay techniques for tracking LENZ Therapeutics Inc.M&A Rumor & Safe Swing Trade Setups - newser.com
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Lenz Therapeutics Third Quarter 2025 Financial Results and Business Update - LENZ Therapeutics
LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025 - The Manila Times
LENZ Therapeutics (LENZ) to Release Quarterly Earnings on Wednesday - MarketBeat
Lenz Therapeutics Inc (LENZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lenz Therapeutics Inc 주식 (LENZ) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital VI, L. | 10% Owner |
Sep 30 '25 |
Sale |
46.01 |
92,030 |
4,234,695 |
764,127 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 18 '25 |
Sale |
42.23 |
90,654 |
3,828,632 |
1,183,543 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 18 '25 |
Sale |
42.23 |
44,650 |
1,885,724 |
856,157 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 25 '25 |
Sale |
39.54 |
52,419 |
2,072,738 |
1,321,640 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 26 '25 |
Sale |
39.01 |
47,443 |
1,850,891 |
1,274,197 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 22 '25 |
Sale |
40.15 |
26,161 |
1,050,392 |
1,374,059 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 25 '25 |
Sale |
39.54 |
25,818 |
1,020,888 |
924,175 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 26 '25 |
Sale |
39.01 |
23,368 |
911,655 |
900,807 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 22 '25 |
Sale |
40.15 |
12,885 |
517,356 |
949,993 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 15 '25 |
Sale |
39.50 |
145,051 |
5,729,514 |
1,430,848 |
0.21%
0.74%
자본화:
|
볼륨(24시간):